Get the Stockscreener App
0.6649
9.14%
0.0557
After Hours:
.68
0.0151
+2.27%
Seastar Medical Holding Corp stock is traded at $0.6649, with a volume of 1.86M.
It is up +9.14% in the last 24 hours and down -31.52% over the past month.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
See More
Previous Close:
$0.6092
Open:
$0.6249
24h Volume:
1.86M
Relative Volume:
0.32
Market Cap:
$7.45M
Revenue:
-
Net Income/Loss:
$-26.23M
P/E Ratio:
-0.5417
EPS:
-1.2274
Net Cash Flow:
$-10.29M
1W Performance:
+8.31%
1M Performance:
-31.52%
6M Performance:
-62.01%
1Y Performance:
-91.44%
1-Day Range:
$0.5937
$0.675
1-Week Range:
$0.5111
$0.675
52-Week Range:
$0.3054
$9.5599
Seastar Medical Holding Corp Stock (ICU) Company Profile
Name
Seastar Medical Holding Corp
Sector
Industry
Phone
844-427-8100
Address
3513 BRIGHTON BLVD, DENVER
Compare ICU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
0.6649 | 9.91M | 0 | -26.23M | -10.29M | -1.2274 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Seastar Medical Holding Corp Stock (ICU) Latest News
The ICU Stock Puzzle: Unraveling SeaStar Medical Holding Corp’s Fluctuating Performance - investchronicle.com
Leading Children's Hospital Adopts Revolutionary QUELIMMUNE Kidney Therapy as Trial Nears Completion - Stock Titan
How SeaStar Medical Holding Corporation stock performs during market volatilityTop ROI Selections - Newser
How SeaStar Medical Holding Corporation Equity Warrant stock performs during market volatilityFree Investing Community - Newser
Why SeaStar Medical Holding Corporation stock attracts strong analyst attentionProfessional Stock Screener - Newser
What makes SeaStar Medical Holding Corporation Equity Warrant stock price move sharplyFree VIP Investment Strategies - Newser
What makes SeaStar Medical Holding Corporation stock price move sharplyFree Trading Strategy Suggestions - Newser
SeaStar Medical announces registered direct offering - Medical Buyer
SeaStar Medical raises $4 million in at-market offering By Investing.com - Investing.com South Africa
SeaStar Medical raises $4 million in at-market offering - Investing.com
SeaStar Medical announces $4M registered direct offering - TipRanks
ICU pauses $7.4M ATM, leaves $6.2M unused – dilution on hold | ICU SEC FilingForm 424B5 - Stock Titan
SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI) - Yahoo Finance
SeaStar Medical shareholders approve director elections and equity plan changes - Investing.com Nigeria
SeaStar Medical shareholders approve director elections and equity plan changes By Investing.com - Investing.com South Africa
Revolutionary QUELIMMUNE Treatment Cuts Pediatric AKI Deaths by 50% at Texas Children's Hospital - Stock Titan
Medical Holding Corporation regains Nasdaq compliance - Investing.com
SeaStar Medical’s QUELIMMUNE Shows Promise in Treating Pediatric AKI - citybuzz -
Director Makes Major Move with SeaStar Medical Stock Purchase - TipRanks
SeaStar Medical completes transactions to regain Nasdaq compliance By Investing.com - Investing.com India
Life-Saving QUELIMMUNE Therapy Success Featured by Cincinnati Children's Hospital | ICU Stock News - Stock Titan
SeaStar Medical Holding Corp Inc. (ICU) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
SeaStar Medical stock plunges after pricing million public offering - Investing.com Australia
SeaStar Medical Announces Pricing of Up to $8 Million Public Offering - The Manila Times
SeaStar Medical prices $4 million public offering at $0.65 per share - Investing.com Nigeria
Short Interest in SeaStar Medical Holding Corporation (NASDAQ:ICU) Rises By 29.5% - Defense World
ICU Secures U.S. DoD Grant for Advanced Burn and Injury Research - GuruFocus
Military Selects SeaStar Medical from 160 Companies for Critical Burn Treatment Research Grant - Stock Titan
How SeaStar Medical Is Leveraging Its Breakthrough Medical Device Designation To Help Critically Ill Patients - MSN
SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market - Yahoo Finance
SeaStar Medical secures second CMS trial coverage By Investing.com - Investing.com South Africa
SeaStar Medical (ICU) Secures CMS Coverage for Clinical Trial Ex - GuruFocus
SeaStar Medical secures second CMS trial coverage - Investing.com
SeaStar Medical Wins Elite CMS Coverage Status: Only 100 Trials Get This Medicare Advantage - Stock Titan
SeaStar Medical Advances Organ-Saving Therapies for Critically Ill Patients - citybuzz -
SeaStar Medical (ICU) Announces Offering of Common Stock Shares | ICU Stock News - GuruFocus
Prediction: Rocket Lab USA Is Going Global - The Globe and Mail
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
SeaStar Medical Holding Corporation (NASDAQ:ICU) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: SeaStar Medical sees revenue surge in Q1 2025 - Investing.com
SeaStar Medical Holding Corp reports results for the quarter ended March 31Earnings Summary - TradingView
SeaStar Medical Holding Corp SEC 10-Q Report - TradingView
SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance
SeaStar Medical (ICU) Hits Key Milestone in Clinical Trial | ICU Stock News - GuruFocus
SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury - Yahoo Finance
SeaStar Medical to Report First Quarter Financial Results on May 14, 2025 - Stock Titan
Medical Device Co. SeaStar Seeks Toss Of Shareholder Suit - Law360
SeaStar Medical To Report First Quarter Financial Results On May 14, 2025 - Barchart.com
ICUSeaStar Medical Holding Corp Latest Stock News & Market Updates - Stock Titan
SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately - Bluefield Daily Telegraph
Seastar Medical Holding Corp Stock (ICU) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):